Sponsor or institution
Clinical trials and research at Hrain Biotechnology Co., Ltd.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Hrain Biotechnology Co., Ltd. that are recruiting, in China. By phase: Early Phase 1 (2), Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Safety and tolerability test of anti-CD70 T-cell therapy in advanced RCC | Phase 1 | Shanghai | Recruiting | Jun 15, 2026 |
| Evaluating a new CAR-T cell treatment for relapsed or refractory Acute Myeloid Leukemia | Early Phase 1 | Suzhou, Jiangsu | Recruiting | Jan 6, 2025 |
| Evaluating a new CAR-NK cell treatment for relapsed multiple myeloma and plasma cell leukemia | Early Phase 1 | Shanghai, Shanghai Municipality | Recruiting | Sep 21, 2023 |
| BCMA CAR-T cell therapy for relapsed/refractory multiple myeloma | Phase 2 | Shanghai, Shanghai Municipality and 1 other locations | Recruiting | Oct 26, 2022 |
All recruiting trials (4)
-
Safety and tolerability test of anti-CD70 T-cell therapy in advanced RCC
This study tests a CD70-targeted CAR-T cell therapy in adults with advanced or metastatic renal cell carcinoma to see if it is safe and tolerable and to identify a usable dose for future studies.
-
Evaluating a new CAR-T cell treatment for relapsed or refractory Acute Myeloid Leukemia
This study is testing a new CAR-T cell treatment to see if it can help people with relapsed or hard-to-treat Acute Myeloid Leukemia feel better.
-
Evaluating a new CAR-NK cell treatment for relapsed multiple myeloma and plasma cell leukemia
This study is testing a new CAR-NK cell treatment to see if it can help people with relapsed multiple myeloma or plasma cell leukemia feel better and improve their condition.
-
BCMA CAR-T cell therapy for relapsed/refractory multiple myeloma
This study is testing a new CAR-T cell therapy for people with relapsed or hard-to-treat multiple myeloma to see if it can help them feel better and improve their condition.
Quick answers
How many clinical trials run by Hrain Biotechnology Co., Ltd. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 2, Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.